Arabian Health Care Supply CO Pharmaceutical Import Profile — Saudi Arabia (DGFT 2022–2026)

Name: Arabian Health Care Supply CO Pharmaceutical Import Records from India — 2 Products, $406.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Arabian Health Care Supply CO — Pharmaceutical Importer Profile (2026) | 2 Products, $406.4K Trade | TransData Nexus

Who Are the Verified Indian Suppliers to Arabian Health Care Supply CO?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Emcure Pharmaceuticals Limited	$1.2M	53	100.0%

Arabian Health Care Supply CO sources from 1 verified Indian supplier across 40 distinct formulations. The sourcing is highly concentrated — Emcure Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Arabian Health Care Supply CO Import?

Formulation	Value	Ships
Pharma: cidofovir injection 375MG/5ML	$150.0K	3
Pharma: bicnu 100MG injection	$134.8K	5
Pharmaceuticals products( finished product): megval 50 MG INJ 1 vial(melphalan hydrochloride for injection 50MG/vial)	$94.7K	2
Pharma: megval injection (melphalan	$86.0K	3
Pharma prod finished prod generic name phenylephrine hcl 10 MG INJ 10x1 vial phenylephrine hcl injection 10MG ML	$50.0K	1
Pharmaceutical article / ods / product / item finished product - bicnu 100 MG INJ 1 vial carmustinefor injection USP 100MG	$50.0K	1
Pharma: imtus 100 MG injection (irinotecan hydrochloride injection 100MG/5ML)-1vial(inv.no.: 2402300696 dt. 07.02.2024	$50.0K	1
Pharmaceuticals products finished product bicnu 100 MG INJ 1 vial carmustine forinjection USP 100MG	$50.0K	1

Arabian Health Care Supply CO imports 40 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

What Products Does Arabian Health Care Supply CO Import?

Top Products by Import Value

1Melphalan$232.7K 2Carmustine$173.7K

Arabian Health Care Supply CO Therapeutic Categories — 1 Specializations

Arabian Health Care Supply CO imports across 1 therapeutic categories, with Advanced Oncology (100.0%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Advanced Oncology

2 products · 100.0% · $406.4K

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Melphalan	Advanced Oncology	$232.7K	8	1.8%	9
2	Carmustine	Advanced Oncology	$173.7K	4	0.8%	10

Key Metrics

Total Import Value$406.4K

Products2

Shipments12

Categories1

CountrySaudi Arabia

#1 Rankings0

Indian Suppliers1

Formulations40

Top Categories

Advanced Oncology100.0%

Indian Suppliers

Last updated: March 28, 2026

Arabian Health Care Supply CO — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Arabian Health Care Supply Company (AHCSC), established in 1979, is a prominent distributor of medical and pharmaceutical products in Saudi Arabia. Headquartered in Riyadh, the company operates under the auspices of the Olayan Group, a private multinational enterprise with diverse commercial and industrial interests across the Middle East. AHCSC's extensive product portfolio includes medical equipment, pharmaceuticals, and critical care products, sourced from renowned international partners. The company has offices in major cities throughout Saudi Arabia, offering full geographical coverage.

2Distribution Network

AHCSC's distribution network spans key regions in Saudi Arabia, with offices in Riyadh, Al Khobar, and Dammam. The Riyadh headquarters is located at Olayan Plaza, Al Ahsa Street, Malaz District. The Al Khobar branch is situated at 86G3+7VG, King Fahd Road, Al Jawharah, Al Khobar 34431. The Dammam branch is located at C523+8VW, Al Khalidiyyah Al Janubiyyah, Dammam 32226. This strategic positioning enables AHCSC to effectively serve the diverse healthcare needs across the Kingdom.

3Industry Role

Supplier Relationship Intelligence — Arabian Health Care Supply CO

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

AHCSC's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from a single supplier, Emcure Pharmaceuticals Limited. This dependency suggests a strategic choice to maintain a streamlined supply chain and potentially leverage favorable terms with a key supplier. However, the limited number of suppliers may pose risks related to supply chain disruptions, pricing fluctuations, and dependency on a single source. The stability of this relationship is crucial for AHCSC's operations, and any changes in Emcure's production capacity, pricing, or regulatory compliance could directly impact AHCSC's ability to meet market demand.

2Supply Chain Resilience

The resilience of AHCSC's supply chain is closely tied to its reliance on Emcure Pharmaceuticals Limited. While this focused sourcing strategy may offer operational efficiencies, it also exposes AHCSC to potential vulnerabilities. The absence of backup suppliers for its imported pharmaceutical products indicates a lack of diversification, which could be problematic in the event of supply disruptions, regulatory changes, or geopolitical issues affecting India. Additionally, the concentration on a single supplier may limit AHCSC's ability to negotiate better terms or adapt to changing market conditions.

3Strategic Implications

AHCSC's concentrated sourcing pattern positions the company to benefit from strong supplier relationships and potential cost advantages. However, this strategy also exposes AHCSC to risks associated with supply chain disruptions and dependency on a single supplier. For Indian exporters, this presents an opportunity to diversify their customer base by offering alternative products or formulations that meet AHCSC's requirements, thereby reducing the company's reliance on a single source and enhancing supply chain resilience.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into Saudi Arabia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Saudi Arabia

1Regulatory Authority & Framework

The Saudi Food and Drug Authority (SFDA) is the primary regulatory body overseeing the safety, efficacy, and quality of pharmaceutical products in Saudi Arabia. The SFDA enforces the Law of Pharmaceutical Establishments and Products (2023), which governs the manufacturing, importing, exporting, registration, and marketing authorization of medicinal products. This comprehensive legislation ensures that all pharmaceutical products meet stringent standards before entering the Saudi market.

2Import Licensing & GMP

Importing pharmaceutical products into Saudi Arabia requires obtaining an import license from the Ministry of Health. Additionally, a Certificate of Free Sale and a certificate of analysis are mandatory for pharmaceutical imports. These documents verify that the products are authorized for sale in the exporting country and meet specific quality standards. The SFDA also requires that manufacturing facilities adhere to Good Manufacturing Practice (GMP) standards, which are recognized internationally, including EU GMP, WHO GMP, and PIC/S certifications. Compliance with these standards is essential for obtaining the necessary import approvals.

3Quality & Labeling

Pharmaceutical products imported into Saudi Arabia must undergo batch testing to ensure they meet the SFDA's quality standards. Stability studies are required to confirm that products maintain their efficacy and safety throughout their shelf life. Labeling must be in Arabic and include essential information such as the product's name, dosage form, strength, manufacturing and expiry dates, storage conditions, and the manufacturer's details. Serialization mandates are in place to facilitate traceability and prevent counterfeit products from entering the market. (sfda.gov.sa)

4Recent Regulatory Changes

Between 2024 and 2026, Saudi Arabia implemented several regulatory changes affecting pharmaceutical imports. The most significant was the enactment of the Law of Pharmaceutical Establishments and Products (2023), which introduced comprehensive regulations governing the lifecycle of medicinal products, including manufacturing, importing, exporting, registration, and marketing authorization. This law aligns Saudi Arabia's pharmaceutical regulations with international standards and enhances the SFDA's oversight capabilities.

TransData Nexus Research · Saudi Arabia regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: Arabian Health Care Supply CO identified across shipments using consignee name normalization, aggregating 2 name variants.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as Arabian Health Care Supply CO's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 12 individual customs records matching Arabian Health Care Supply CO.
5.Supplier Verification: Arabian Health Care Supply CO sources from 1 verified Indian suppliers across 40 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2 Products Tracked

1 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Arabian Health Care Supply CO

Arabian Health Care Supply CO — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Arabian Health Care Supply CO?

What Formulations Does Arabian Health Care Supply CO Import?

What Products Does Arabian Health Care Supply CO Import?

Top Products by Import Value

Arabian Health Care Supply CO Therapeutic Categories — 1 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Indian Suppliers

Arabian Health Care Supply CO — Corporate Profile & Information

1Company Overview

2Distribution Network

3Industry Role

Related Trade Data

Need Detailed Data?

Supplier Relationship Intelligence — Arabian Health Care Supply CO

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Saudi Arabia — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

Arabian Health Care Supply CO — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to Arabian Health Care Supply CO

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — Arabian Health Care Supply CO

What products does Arabian Health Care Supply CO import from India?

Who supplies pharmaceuticals to Arabian Health Care Supply CO from India?

What is Arabian Health Care Supply CO's total pharmaceutical import value?

What therapeutic categories does Arabian Health Care Supply CO focus on?

Get Full Arabian Health Care Supply CO Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology